Fluorescent Nanoprobes as a Biomarker for Increased Vascular Permeability: Implications in Diagnosis and Treatment of Cancer and Inflammation-Reference-Cited by-同舟云学术

Fluorescent Nanoprobes as a Biomarker for Increased Vascular Permeability: Implications in Diagnosis and Treatment of Cancer and Inflammation

Published:2009-12-03 Issue:1 Volume:21 Page:93-101
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Sandanaraj Britto S.¹,Gremlich Hans-Ulrich¹,Kneuer Rainer¹,Dawson Janet¹,Wacha Stefan¹

Affiliation:

1. Global Imaging Group and Department of Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc900311h

Reference57 articles.

1. The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes

2. Biomarkers in drug discovery and development

3. Clinical biomarkers in drug discovery and development

4. Biomarkers in Drug Discovery and Development: From Target Identification through Drug Marketing

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanosensors and their applications in early diagnosis of cancer;Sensing and Bio-Sensing Research;2023-08

2. Original and liposome-modified indocyanine green–assisted fluorescence study with animal models;Lasers in Medical Science;2023-06-17

3. Targeted Nanocarriers-based Approach For Prostate Cancer Therapy;Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective;2023-03-05

4. Imaging techniques in drug development;Indian Journal of Pharmacology;2022-09

5. Nanoparticles and prostate cancer;Nano Drug Delivery Strategies for the Treatment of Cancers;2021